Article

Eyefinity launches Tura, REM Eyewear on Eyefinity.com

Rancho Cordova, CA?Eyefinity, a leading Internet portal for the optical industry, has entered into e-commerce partnerships with Tura L.P. and REM Eyewear. The agreement will make Tura and REM Eyewear products available online through Eyefinity.com.

Rancho Cordova, CA-Eyefinity, a leading Internet portal for the optical industry, has entered into e-commerce partnerships with Tura L.P. and REM Eyewear. The agreement will make Tura and REM Eyewear products available online through http://Eyefinity.com/.

"This relationship allows us to provide another benefit to private eye-care practitioners, particularly since servicing this segment of our industry is one of the attributes on which Tura has built its 60-year legacy," said John Weir, Tura's general manager.

"We are very happy to partner with Eyefinity. The synergy enables both companies to enhance their mutual commitment to exceptional service further and to support to the independents," added Alex Papadopoulos, REM Eyewear's vice president of sales.

REM Eyewear offers frames with brand names, such as Barbie, Converse, Esquire, and Cosmopolitan, as well as house brands Plus+ and Rembrand.

Eyefinity, in conjunction with industry-leading partners, provides e-commerce, marketing, and business management solutions to the private practice eye-care community. Eyefinity is located online at http://www.eyefinity.com/.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
At CIME 2025, Neda Shamie, MD, answers questions about Demodex blepharitis
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
© 2025 MJH Life Sciences

All rights reserved.